The nature and physiological importance of high-density lipoprotein (HDL) binding sites on unstimulated (resting) and mitogen-activated (blast) human peripheral blood lymphocytes were investigated. Specific HDL binding on resting and blast T-lymphocytes was saturable at 50 /ug of '25l-HDL/ml and of high affinity, with Kd values of 8.1 x 10-8 M and 6.5 x 10-8 M, respectively, and Bmax values of 79 ng and 180 ng/mg of cell protein respectively at 4 'C. Binding of HDL double-labelled with fluorescent dioctadecylindocarbocyanine (Dil) and isotope (1251) as well as of single fluorescence-or isotope-labelled HDL was inhibited competitively by HDL apoproteins. Studies of the cholesterol flux between the cells and HDL showed that HDL, low-density lipoprotein (LDL) or BSA at a concentration of 100 ,tg/ml in the tissue culture medium did not result in a significant difference in exogenous [3H]cholesterol efflux from the cell membrane at 37 'C. Proliferating T-blasts incorporated more cholesterol from HDL or LDL than did resting lymphocytes. When the cells were pulsed with 1251-HDL and chased in fresh lipid-free medium, up to 800% of the radioactivity released was not precipitable with trichloroacetic acid. This percentage decreased in a competitive manner when unlabelled HDL was present in the chase incubation medium. Finally, cultivation of lymphocytes with conditioned medium from macrophages increased Dil-HDL binding/uptake, while it was decreased by mevinolin-induced inhibition of hydroxymethylglutarylcoA reductase. In conclusion, human lymphocytes possess a HDL binding site (receptor) responsible for lipid binding/uptake and concomitant internalization and degradation of apoproteins from HDL, but not for reverse cell membrane cholesterol transport. The activity of the binding site is up-regulated during cell proliferation and downregulated during cell growth suppression.
INTRODUCTION
Low-density lipoproteins (LDL) are believed to deliver cholesterol to peripheral cells [1] , while high-density lipoproteins (HDL) remove excess cholesterol from these cells and transport it to the liver for catabolism or excretion. This probably contributes to the protective effect of HDL from atherosclerosis [2] . LDL are internalized and degraded following binding to their receptor on the cell membrane [1] . For reverse cholesterol transport, the interaction of HDL with a specific cell membrane receptor may be necessary [3] . However, the pathophysiological function of this binding site (receptor) has not yet been fully elucidated at the molecular level. One controversy with regard to the HDL pathway is whether HDL bound to its surface receptor/binding site is internalized into the cells, or shows reversible binding to the plasma membrane to provide or remove cellular cholesterol without internalization. Oram et al. [4] showed that cholesterol-loaded mouse peritoneal macrophages exhibited specific binding of HDL, but cell-surface-bound HDL particles were not internalized. However, morphological analyses by Schmitz et al. [5] and Takahashi et al. [6] using the same type of cells revealed that gold-labelled HDL particles were indeed internalized and delivered to endosomes, followed by retroendocytosis. Moreover, a third type of HDL interaction with macrophages and Hep G2 cells, reported by Rinninger and co-workers [7, 8] , consisted of HDL particle uptake and selective utilization of HDL-associated cholesteryl esters by the cells, without parallel apoprotein degradation.
In previous studies we have applied a flow cytometric technique using dioctadecylindocarbocyanine (Dil)-labelled lipoproteins to investigate the characteristics and physiological relevance of the HDL binding site, which recognizes apoprotein (apo) Al as a ligand, on unstimulated and mitogen-activated living human peripheral blood lymphocytes (PBL). At 37°C, specific binding/ uptake of fluorescent HDL was observed in resting T-cells, and T-blasts exhibited significantly elevated Dil-HDL uptake [9, 10] . To further characterize the HDL binding site on resting lymphocytes and mitogen-stimulated T-blasts, lipoproteins labelled with Dil (labelling the lipid fraction) or 12"I (labelling the apoprotein fraction) or both (fluorochrome and isotope simultaneously) were used in the present study. Furthermore, to assess the physiological function of this binding site, the flux of cholesterol between HDL and lymphocytes, as well as the relationship of cell proliferation to HDL binding site activity, were [11] with the following slight modifications: 26 mg of HDL was incubated in 50 ml of lipoproteindeficient plasma with 980 ,g of Dil solubilized in 650 1l of dimethyl sulphoxide for 8 h at 37 'C. After adjusting the density to 1.225 g/ml with KBr, Dil-HDL was re-isolated by ultracentrifugation [10, 12] .
Lipoproteins were iodinated with 125I (Amersham International, Amersham, Bucks., U.K.) by the method of Sinn et al. [13] , which is known to yield higher labelling efficiencies (80-90 %) and milder pH (7.6 ). For double labelling, lipoproteins (5 [10] .
Isolation and cultivation of PBL Blood donors were of both sexes, aged 20-35 years. Mononuclear cells were isolated from freshly drawn anti-coagulated (heparin) peripheral blood by density gradient centrifugation over Lympho-Paque (Nyegaard & Co., Oslo, Norway; density 1.086 g/l) as described [12] . Monocytes were depleted by plastic adherence in tissue culture flasks (Falcon, Becton Dickinson & Co., Oxnard, CA, U.S.A.). The harvested cells were referred to as PBL [9, 10, 12] .
Serum at 4°C for 10 min at 800g. An aliquot of the supernatant was precipated by 0.125 M-trichloroacetic acid followed by centrifugation. The pellet and supernatant were counted for radioactivity separately in the y-radiation counter in terms of trichloroacetic acid-insoluble (precipitable) and trichloroacetic acid-soluble (non-precipitable) products. Finally the cells were dissolved in 0.1 M-NaOH, and the amount of cell-associated radioactivity and the protein content were determined.
After chase incubation for 4 h as described above, the incubation medium was collected and chromatographed at room temperature on a 1.2 cm x 15 cm column ofSephadex G-25 equilibrated in Tris buffer containing 0.1 % BSA. The column was eluted with the same buffer and fractions of 10 drops (about 0.33 ml) were collected and counted. The column was calibrated using 1251-HDL solution containing about 1 % free 125I.
Cells preincubated with 1251-HDL at 4°C after washing were first incubated at 4°C or 37°C for 5 min with or without trypsin (1 mg/ml), or at 37°C for 5 min and then for another 5 min with trypsin. These cell suspensions were then centrifuged at 800 g for 10 min at 4 'C. Radioactivity of the cells and supernatants was determined in a y-radiation counter.
T-blasts were incubated with 1251-HDL at 4 'C with or without 100 liM-chloroquine (Sigma) or 10 mM-NH4Cl for 2 h. After washing, the cells were re-incubated at 37 'C in the presence or absence of chloroquine or NH4C1 for 2 h. Radioactivity in both the cells and supernatants was determined. (Fig. 1) , indicating that the binding sites on both resting T-cells and T-blasts are of similar affinity but different capacity.
To further characterize the relationship between HDL lipid and apoprotein binding/uptake, competition experiments were carried out with HDL subjected to different labelling procedures. As shown in Fig. 2 
Degradation of HDL by lymphocytes
The initial incubation with 1251-HDL was performed at 4°C and the chase was carried out at 37°C or 4 'C. The results show that, at 37 'C, the cells progressively released small-molecularmass radioactive molecules into the medium, such that after 3 h only about 20-30 % of the originally bound '25I-HDL remained associated with the cells. There was a rapid release rate of 1251 radioactivity from cells carrying receptor-bound 125I-HDL during the initial chase incubation (Fig. 5a) . At only 10-20 % of the radioactivity present in the medium was precipitable with 0.125 M-trichloroacetic acid (Fig. 5b) , and 80-90 % was not precipitable (Fig. Sc) . Similar release patterns of bound 1251-HDL were observed in resting PBL and T-blasts, although the amounts of cell-bound and released radioactivity were less in the resting lymphocytes (Fig. 5) . Cells incubated at 4°C released only 10-20 % of the initially bound radioactivity in 3 h, compared to 80-900% by the cells incubated at 37°C, indicating that the release of cell-bound radioactivity is an energy-dependent process.
The effect of unlabelled HDL in the chase medium on the release of cell-associated radioactivity by T-blasts is shown in Fig. 6(a) . The amount of trichloroacetic acid-precipitable radioactivity released was higher in the presence of unlabelled HDL (Fig. 6b) . Specifically, increased precipitable radioactivity was reflected by lower cell-associated and trichloroacetic acid-soluble radioactivity (Fig. 6c) . These results suggest that the presence of unlabelled HDL in the chase medium enhanced lipoprotein release, resulting in increased radioactivity in the medium.
The radioactive products released during the chase period by T-blasts preincubated with 125I-HDL were further analysed by gel filtration chromatography (Fig. 7) . As a control, 1251-HDL was incubated for 3 h at 37°C in the same medium as was used for cell culture. The 1251-HDL and chase-incubated-cell media were passed over the column, and sharp high-and low-molecularmass peaks were obtained. The former generally corresponded to the intact HDL fraction, and the latter to amino acids, i.e. metabolized products. In chase-incubated medium only a small peak was observed in the high-molecular-mass fraction. These results complement those of the trichloroacetic acid precipitation experiments (see Fig. 5 ).
On most cell types the HDL binding site has proven relatively resistant to trypsin treatment, but trypsinization can disassociate bound HDL from its cell surface binding site [18] [19] [20] . In the present experiments, trypsin treatment for 5 min at 37°C caused 75 % release of the total bound '25I-HDL from T-blasts, while only 45 % of bound 1211-HDL was released from cells preincubated at 37°C for 5 min before the 5 min trypsinization, indicating that 30 % of cell-associated 1251-HDL was internalized
Interactions of high-density lipoproteins with human lymphocytes during the 5 min preincubation at 37 'C. Furthermore, 100 /ZMchloroquine or 10 mM-NH4CI did not affect HDL binding and degradation on T-blasts (Table 1) .
Relationship between cell proliferation and HDL binding site activity In the present experiments, lymphocytes were studied during two phases, i.e. resting and proliferating. Resting PBL can be stimulated to proliferate in vitro by mitogens, such as PHA, and the rate of cell proliferation correlates positively with increased PHA concentrations up to 25 ,ug/ml. Interestingly, Dil-HDL and Dil-LDL binding/uptake by the cells increased in parallel, and reached a plateau at PHA concentrations of 5-15 ,ug/ml (Fig. 8a) . This increased binding was evident whether the affinity or the number of binding sites changed during proliferation. Saturation curves and Scatchard analysis on resting PBL and Tblasts demonstrated that the number of HDL binding sites increased without affecting binding affinity (Fig. 1) . Furthermore, the increased HDL binding sites on T-blasts were due to increased density rather than an enlarged cell surface, since the total bound Vol. 285 1251I-HDL on the T-blasts was much higher than that on resting PBL based on cellular protein weights (Fig. 5) .
Although the composition of the CM from human macrophages is very complex, several constituent factors are known to promote cell proliferation ofPHA (25 ,ug/ml)-stimulated lymphocytes. In this experiment, the CM only served as a source of growth factors to enhance T-cell proliferation. With increased rates of cell growth at various concentrations of CM (up to 100 %, v/v), up-regulation of Dil-HDL and Dil-LDL binding/ uptake was obtained (Fig. 8b) Elution volume (ml) Fig. 7 . Fractionation of the chase-incubated medium T-blasts were incubated for 2 h with 50 pug of .25I-HDL/ml at 4°C, and chased at 37°C for 3 h. The chase medium (0) containing radioactivity released by T-blasts and the medium containing intact '25I-HDL (0) were chromatographed separately on a Sephadex G-25 1.2 cm x 15 cm column equilibrated with 0.02 M-Tris buffer containing 0. 0% BSA and eluted with the same buffer. Fractions of 300 ,u1 were collected and the radioactivity was determined. (Fig. 8c) .
DISCUSSION
Investigations of HDL binding are complicated by the dynamic exchange of apoproteins and lipids between lipoprotein particles, liposomes and cell membranes. In our previous studies, a fluorescent label (Dil) was chosen to trace the movement of lipids from surface-bound HDL into lymphocytes. Those experiments failed to determine whether this takes place by simple lipid transfer or by internalization of the HDL particles. The requirement for an apoprotein receptor binding for lipid exchange between HDL and cells has been questioned [21, 22] . In the present paper, we address this point by assessing binding/uptake of isotope-and/or fluorescence-labelled HDL on resting T-cells and T-blasts. Three 1 ). No evidence for the specific transport of exogenous cholesterol from the lymphocyte plasma membrane to HDL was found, since HDL, LDL and even BSA showed a similar ability to mediate cholesterol efflux from the cell membrane.
The absence of intact HDL in the chase medium of cultured luteal cells was reported by Rajan & Menon [30] . Our results indicate that retroendocytosis of HDL, reported by several authors [6, 28, 29] , may not occur in lymphocytes since human fibroblasts only degraded less then 20 % of total bound '25l-HDL in a 2 h incubation at 37°C (results not shown). Furthermore, chloroquine andNH4C1, unrelated compounds which can inhibit the lysosomal pathway of HDL degradation [31] , did not inhibit HDL degradation in T-lymphocytes, indicating that a lysosomeindependent process of HDL degradation is involved.
Thus an HDL receptor on human lymphocytes identified by differently labelled HDL may be responsible for binding, internalization and degradation of holo-HDL particles. However, it is difficult to clarify the factors that regulate HDL receptor activity on lymphocytes. Oram et al. [32, 33] showed that HDL receptor activity on fibroblasts, aortic smooth muscle cells and endothelial cells was up-regulated by increased cellular cholesterol content and inhibition of cell proliferation [34] , and down-regulated by serum growth factors [35] and insulin [36] , presumably to prevent loss of intracellular pools of cholesterol needed for membrane synthesis. These results are at variance with our observations on human T-lymphocytes. Mitogen (PHA) can stimulate quiescent T-cells to proliferating blasts, and CM from human monocytes/macrophages promotes PHA-activated cell proliferation in culture. HDL receptor activity is up-regulated on these proliferating T-cells, in contrast to the down-regulation reported by Oppenheimer et al. [34] [35] [36] on human fibroblasts. Obviously, proliferating T-cells require more nutrients from the environment to meet the requirement for cell organelle synthesis. It seems reasonable that HDL may provide more lipids, i.e. phospholipids or fatty acids, by increased activity of the HDL receptor, rather than mediating reverse cholesterol transport from the cells.
LDL receptor activity can obviously be up-regulated by a low cellular cholesterol content. In proliferating T-cells stimulated by PHA or CM, LDL receptor activity up-regulation is dependent on the greater requirement for cholesterol, as further substantiated by the suppression of the mitogen response after inhibition of hydroxymethylglutaryl-coA reductase, the rate-limiting enzyme for intracellular cholesterol synthesis. In this case, LDL receptor activity is increased by more than 100%, due to the decreased intracellular cholesterol content.
The main function of LDL consists of providing cholesterol to proliferating T-cells via the apoB,E receptor, while HDL may also supply lipids to these cells via its receptor. HDL was not considered to be a cholesterol donor for the cells because HDL receptor activity was down-regulated by decreased intracellular cholesterol content, e.g. when synthesis of endogenous cholesterol was inhibited by mevinolin in mitogen stimulation tests under serum-free conditions. Exogenous fatty acids or phospholipids may be provided by HDL in lipid-free medium, since cultured lymphocytes required an exogenous source of fatty acids or phospholipids for optimal proliferation in response to mitogens [16, [37] [38] [39] [40] . When cell proliferation was suppressed by inhibition of hydroxymethylglutaryl-coA reductase, the activity of the HDL receptor was decreased, possibly because less fatty acids or phospholipids were required under these unfavourable conditions.
